In News:

The recent outbreak reported in the first week of December 2024 in the Democratic Republic of Congo, which has claimed over 400 lives and remains unclassified, has raised concerns that it could be an instance of Disease X.

What is Disease X?

• Definition: Disease X is a hypothetical, unidentified pathogen that has the potential to cause a global health crisis, either as an epidemic or pandemic.
• Origins: Could arise from zoonotic spillover (animal-to-human transmission), antimicrobial resistance, bioterrorism, or lab accidents.
• Severity: Predicted to be 20 times more lethal than SARS-CoV-2, with rapid transmission and significant mortality.
• Features: Represents unknown threats, including viruses, bacteria, fungi, or prions.
• Emergence Factors: Driven by deforestation, urbanization, climate change, and human-wildlife interactions.

Historical Context

• Conceptualization: The term was coined by the World Health Organization (WHO) in 2018, post the 2014–2016 Ebola outbreak, which revealed gaps in global health responses.
• Zoonotic Origins: Around 70% of emerging diseases since 1940 have zoonotic origins, linked to human encroachment on wildlife habitats.

WHO’s Priority Pathogen List

• Purpose: To focus global resources and attention on diseases with high epidemic or pandemic potential but lacking sufficient vaccines or treatments.
• Pathogens Listed: Includes Ebola, Marburg, Lassa fever, Nipah virus, Rift Valley fever, Zika virus, and Disease X.
• Criteria: These diseases have high mortality rates, potential for rapid spread, and inadequate preventive or therapeutic options.

Why Disease X is a Concern

• Unpredictability: Its emergence, transmission, and impact remain uncertain, making preparedness challenging.
• Globalization: Increased global travel and trade facilitate rapid spread of diseases across borders.
• Environmental Drivers: Climate change, urbanization, and deforestation disrupt ecosystems, bringing humans into closer contact with wildlife and pathogens.

Patterns in Emerging Diseases

• Zoonotic Spillover: The majority of emerging diseases originate from animals, with over 1.7 million undiscovered viruses in wildlife that could infect humans.
• Increased Outbreaks: Since the mid-20th century, the frequency of new diseases has risen, reflecting environmental, demographic, and global factors.

Challenges in Predicting Disease X

• Uncertainty: The vast pool of potential pathogens (viruses, bacteria, fungi, etc.) makes it difficult to predict the exact nature, origin, or timing of Disease X.
• Environmental and Climatic Changes: Climate change reshapes disease transmission dynamics, expanding the range of diseases like malaria and dengue.
• Technological and Knowledge Gaps: Many pathogens that could cause pandemics are still unidentified. Genomic sequencing and AI are advancing but cannot fully predict Disease X.

Global Preparedness Initiatives

• WHO's Role: WHO’s priority pathogen list and Pandemic Treaty aim to ensure coordinated, global responses to future outbreaks.
• Pandemic Fund: Supports strengthening health systems, especially in low-income countries.
• mRNA Vaccine Hubs: Enhance vaccine production capacity, particularly in developing countries.
• Coalition for Epidemic Preparedness Innovations (CEPI): Works on "prototype pathogen" platforms to create vaccines within 100 days of identifying a new disease.

Indian Initiatives for Disease Surveillance and Preparedness

• Integrated Disease Surveillance Programme (IDSP): Tracks outbreaks, monitors trends, and strengthens the country’s epidemic preparedness.
• National Institute of Virology (NIV): Focuses on researching viral pathogens and zoonotic diseases.
• Biotech Initiatives: Indigenous vaccine development and diagnostic tools are crucial for combating future outbreaks.
• Emergency Response Fund: Allocates resources to support immediate pandemic response efforts.

Key Challenges in Tackling Disease X

• Prediction Complexity: The interactions between humans, animals, and the environment are too complex to predict the exact nature of Disease X.
• Health Disparities: Low- and middle-income countries often lack the infrastructure to effectively combat pandemics, making them more vulnerable.
• Climate Change: Alters transmission dynamics, expanding the range of diseases carried by vectors like mosquitoes.

Way Forward

• Strengthening Surveillance: Implementing real-time genomic sequencing and AI-driven tools for early outbreak detection.
• Global Cooperation: Promoting equitable sharing of vaccines, diagnostics, and treatments to ensure timely and efficient responses.
• Public Health Infrastructure: Invest in strengthening healthcare systems, especially in high-risk regions like the Congo Basin.
• Research and Development: Focus on universal vaccines, diagnostic tools, and prototype pathogen platforms that can be quickly adapted to new diseases.